🔴 Edesa Biotech is trading 6.5% down today as technical pressure extends last week's selloff

Edesa Biotech is trading 6.5% down at $4.89 in pre-market, extending last week’s volatility-driven selloff in the thinly traded biotech name.

• The move appears tied to continued technical pressure as there are no fresh company-specific headlines, earnings, or regulatory updates this morning.
• The decline comes despite broader U.S. equity futures trading higher, highlighting the stock's decoupling from the wider market sentiment.